GENE ONLINE|News &
Opinion
Blog

CSL Behring
Will Breakthrough Therapy Lead the Way? An Overview of the Approved Gene and Cell Therapies for 2022
2023-01-13
Hemgenix Marks Most Expensive Treatment Ever and First Gene Therapy for Hemophilia B
2022-11-22
Australia’s CSL Makes $11.7 Billion Bid for Swiss Drugmaker Vifor
2021-12-15
uniQure’s Gene Therapy Impresses in Pivotal Trial Raising Hopes of a Hemophilia B Cure
2020-11-22
CSL Behring to Tackle Hemophilia B Using UniQure’s Gene Therapy Program
2020-06-28
SAB Biotherapeutics Mines Cow’s Antibodies for Treating COVID-19
2020-06-17
LATEST
Pharming announces US FDA approval of Joenja® (leniolisib) as the first and only treatment indicated for APDS
2023-03-24
Moderna Injects $76 Million To Kickstart Lipid Nanoparticle Delivery Partnership With Generation Bio
2023-03-24
Shining a Light on Oncology with Rakuten Medical Co-CEO Takashi Toraishi
2023-03-23
Incyte’s Zynyz Secures FDA Approval for Treating a Rare and Aggressive Skin Cancer
2023-03-23
Biohaven Licenses TYK2/JAK1 Dual Inhibitor From China’s Highlight In $970 Million Pact
2023-03-23
FDA Extends Approval Of Regeneron’s Evkeeza For Inherited High Cholesterol
2023-03-23
Launching an Innovative Product, PlaClin-M, for Safe Environments in the Pandemic Era.
2023-03-23
Scroll to Top